<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Despite massive delays, Novavax is expected to obtain the US FDA’s Emergency Use Authorization for its COVID-19 vaccine, NVX-CoV2373, in the coming weeks. Given that Israel just ordered 5M of NVX-CoV2373, it could be a strong indication that the mRNA vaccines are less effective against the globally dominant Omicron variant.
...read full article on Seeking Alpha
